SCHEMBL6987117

SCHEMBL6987117

CC(C)(C)OC(=O)NCCOc1noc2c(C#N)cc(Cl)cc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 1/20 0.39
IDO1 P14902 3/20 0.38
CA12 O43570 2/20 0.38
CA1 P00915 2/20 0.38
CA2 P00918 2/20 0.38
CA9 Q16790 2/20 0.38
NSD2 O96028 1/20 0.36
STK17B O94768 1/20 0.36
STK17A Q9UEE5 1/20 0.36
CYP1A1 P04798 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2B6 P20813 1/20 0.36
CYP2C19 P33261 1/20 0.36
CYP3A43 Q9HB55 1/20 0.36
RET P07949 1/20 0.34
KDM4E B2RXH2 2/20 0.34
LMNA P02545 1/20 0.34
PDK2 Q15119 1/20 0.34
MEN1 O00255 1/20 0.34
ALDH1A1 P00352 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6989160 0.88 IDO1 (0.44) IDO1CA12CA1CA2CA9
SCHEMBL6989360 0.87 IDO1 (0.39) IDO1CA12CA1CA2CA9
SCHEMBL6987703 0.85 CA12 (0.40) KCNH2IDO1CA12CA1CA2
SCHEMBL6987906 0.84 CA12 (0.40) IDO1CA12CA1CA2CA9
SCHEMBL6994824 0.82 IDO1 (0.44) IDO1NSD2CYP2C19KDM4ELMNA
SCHEMBL6989587 0.79 FAAH (0.49) IDO1CA12CA1CA2CA9
SCHEMBL6991027 0.79 STK17B (0.40) IDO1CA12CA1CA2CA9
SCHEMBL6991241 0.79 CA12 (0.40) KCNH2IDO1CA12CA1CA2
SCHEMBL6988016 0.77 ALDH1A1 (0.49) IDO1CA12CA1CA2CA9
SCHEMBL6986485 0.77 LMNA (0.44) IDO1CA12CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0779281-B1 ISOXAZOLES SANKYO CO (JP) 2003-10-29 EP disclosed
US-6096771-A ISOXAZOLE DERIVATIVES EXHIBITING EXCELLENT TYPE B AND TYPE A MONOAMINE OXIDASE INHIBITORY ACTIVITIES, THEREFORE USEFUL FOR PREVENTING PARKINSON'S DISEASE, DEPRESSION AND ALZHEIMER'S DISEASE SANKYO COMPANY, LIMITED (JP) 2000-08-01 US disclosed
US-5965591-A MONOAMINE OXIDASE INHIBITOR; FOR PROPHYLAXIS AND TREATING PARKINSON'S DISEASE, DEPRESSION AND ALZHEIMER'S DISEASE SANKYO COMPANY, LIMITED (JP) 1999-10-12 US disclosed
EP-0779281-A1 ISOXAZOLES SANKYO COMPANY LIMITED (JP) 1997-06-18 EP disclosed